Am J Physiol Cell Physiol AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol (July 12, 2006). doi:10.1152/ajpcell.00030.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/C259    most recent
00030.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoki, H.
Right arrow Articles by Sugano, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoki, H.
Right arrow Articles by Sugano, K.
Submitted on January 25, 2006
Accepted on July 10, 2006

Cyclooxygenase-2 is required for activated pancreatic stellate cells to respond to pro-inflammatory cytokines

Hiroyoshi Aoki1, Hirohide Ohnishi1*, Kouji Hama1, Satoshi Shinozaki1, Hiroto Kita1, Hiroyuki Osawa1, Hironori Yamamoto1, Kiichi Sato1, Kiichi Tamada1, and Kentaro Sugano1

1 Department of Gastroenterology, Jichi Medical School, Japan

* To whom correspondence should be addressed. E-mail: hohnishi{at}jichi.ac.jp.

Cyclooxygenase-2 (Cox-2) mediates various inflammatory responses and is expressed in pancreatic tissue from patients with chronic pancreatitis. To examine the role of Cox-2 in chronic pancreatitis, we investigated its participation in regulating functions of pancreatic stellate cells (PSCs), using isolated rat PSCs. Cox-2 was expressed in culture-activated PSCs but not in freshly isolated quiescent PSCs. TGF-{beta}1, interleukin (IL)-1{beta}, and IL-6 enhanced Cox-2 expression in activated PSCs, concomitantly increasing the expression of {alpha}-smooth muscle actin ({alpha}-SMA), a parameter of PSC activation. The Cox-2 inhibitor NS-398 blocked culture-activation of freshly isolated quiescent PSCs. NS-398 also inhibited the enhancement of {alpha}-SMA expression by TGF-{beta}1, IL-1{beta} and IL-6 in activated PSCs. These data indiate that Cox-2 is required for the initiation and promotion of PSC activation. We further investigated the mechanism by which cytokines enhance Cox-2 expression in PSCs. Adenovirus-mediated expression of dominant-negative Smad2/3 inhibited the increase in expression of Cox-2, {alpha}-SMA, and collagen-1 mediated by TGF-{beta}1 in activated PSCs. Moreover, dominant-negative Smad2/3 expression attenuated the expression of Cox-2 and {alpha}-SMA enhanced by IL-1{beta} and IL-6. Anti-TGF-{beta} neutralizing antibody also attenuated the increase in Cox-2 and {alpha}-SMA expression caused by IL-1{beta} and IL-6. IL-6 as well as IL-1{beta} enhanced TGF-{beta} secretion from PSCs. These data indicate that Smad2/3-dependent pathway plays a central role in Cox-2 induction by TGF-{beta}1, IL-1{beta}, and IL-6. Furthermore, IL-1{beta} and IL-6 promote PSC activation by enhancing Cox-2 expression indirectly through Smad2/3-dependent pathway via increasing TGF-{beta}1 secretion from PSCs.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.